Qiagen to Develop Companion Dx for New Parkinson's Drug

Qiagen is rapidly building a name for itself as the go-to partner for companion diagnostics. The Hilden, Germany-based company currently has master collaboration agreements with more than 25 pharma and biotech companies to develop and commercialize companion diagnostic tests for their drug candidates.